Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

13.25
Delayed Data
As of Dec 13
 +0.60 / +4.74%
Today’s Change
9.30
Today|||52-Week Range
20.45
+9.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-3.5M-55.0M-132.4M-110.2M
 
 
 
 
 
Depreciation703.0K742.0K1.4M1.6M
 
 
 
 
 
Total Other Cash Flow2.8M6.9M49.9M10.5M
 
 
 
 
 
Funds From Operations39.0K-47.4M-81.1M-98.1M
 
 
 
 
 
Funds From/For Other Operating Expenses53.8M-12.0M-8.2M-1.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-53.7M-35.4M-72.9M-96.5M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-229.9M
 
 
Decrease In Investments0.000.000.0065.1M
 
 
Capital Expenditures-630.0K-2.2M-183.0K-624.0K
 
 
 
 
 
Other Investing - Uses0.000.00-40.0M0.00
 
 
Net Cash Flow Investing-630.0K-2.2M-40.2M-165.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00------
Long Term Borrowings0.000.00------
Long Term Debt Reduction0.000.00-441.0K-561.0K
 
 
 
Net Proceeds Stock Sale277.0K103.8M131.8M131.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing82.5M286.0K0.000.00
 
 
 
Other Uses - Financing2.8M--0.000.00
 
 
Net Cash Flow - Financing79.9M104.1M131.3M131.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash25.6M66.5M18.2M-130.5M